{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:12:16Z","timestamp":1783152736718,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32GM008396"],"award-info":[{"award-number":["T32GM008396"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113765"],"award-info":[{"award-number":["R01NS113765"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.expneurol.2024.115025","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T20:21:54Z","timestamp":1729801314000},"page":"115025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Ighmbp2 mutations and disease pathology: Defining differences that differentiate SMARD1 and CMT2S"],"prefix":"10.1016","volume":"383","author":[{"given":"Sara M.","family":"Ricardez Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassil","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Al Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier Llorente","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona O.","family":"Garro Kacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayd","family":"Al Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique A.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2024.115025_bb0005","first-page":"1087","article-title":"Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients","volume":"26","author":"Borgia","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-1119(96)00630-0","article-title":"Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells","volume":"185","author":"Chen","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.expneurol.2024.115025_bb0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajhg.2014.10.002","article-title":"Truncating and missense mutations in IGHMBP2 cause Charcot-Marie tooth disease type 2","volume":"95","author":"Cottenie","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0020","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/hmg\/ddp134","article-title":"Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery","volume":"18","author":"de Planell-Saguer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-005-1056-y","article-title":"The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"110","author":"Diers","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0030","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1542\/peds.2011-0544","article-title":"The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"129","author":"Eckart","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.expneurol.2024.115025_bb0035","doi-asserted-by":"crossref","first-page":"17463","DOI":"10.1016\/S0021-9258(19)85357-7","article-title":"The human S mu bp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region","volume":"268","author":"Fukita","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2024.115025_bb0040","article-title":"The respiratory phenotype of rodent models of amyotrophic lateral sclerosis and spinocerebellar Ataxia","volume":"3","author":"Fusco","year":"2019","journal-title":"J Neuroinflamm Neurodegener Dis"},{"key":"10.1016\/j.expneurol.2024.115025_bb0045","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/302636","article-title":"Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21","volume":"65","author":"Grohmann","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng703","article-title":"Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1","volume":"29","author":"Grohmann","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.10755","article-title":"Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"54","author":"Grohmann","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/humu.20525","article-title":"Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis","volume":"28","author":"Guenther","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2024.115025_bb0065","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/hmg\/ddp028","article-title":"IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1)","volume":"18","author":"Guenther","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-008-0402-7","article-title":"Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease","volume":"87","author":"Guenther","year":"2009","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.expneurol.2024.115025_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejpn.2013.11.006","article-title":"Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells","volume":"18","author":"Jedrzejowska","year":"2014","journal-title":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"},{"key":"10.1016\/j.expneurol.2024.115025_bb0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.resp.2013.05.025","article-title":"Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders","volume":"189","author":"Johnson","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0883073807310989","article-title":"Spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"23","author":"Kaindl","year":"2008","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/awz373","article-title":"ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy","volume":"143","author":"Kannan","year":"2020","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-925X-8-33","article-title":"Repeatability of nerve conduction measurements derived entirely by computer methods","volume":"8","author":"Kong","year":"2009","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.expneurol.2024.115025_bb0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ydbio.2011.05.667","article-title":"Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons","volume":"356","author":"Lee","year":"2011","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.actbio.2023.07.009","article-title":"In vivo shear wave elasticity imaging for assessment of diaphragm function in muscular dystrophy","volume":"168","author":"Lee","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.expneurol.2024.115025_bb0110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.nmd.2022.05.002","article-title":"Clinical and genetic features of Charcot-Marie-tooth disease patients with IGHMBP2 mutations","volume":"32","author":"Lei","year":"2022","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.expneurol.2024.115025_bb0115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/hum.2020.065","article-title":"Intralingual administration of AAVrh10-miR(SOD1) improves respiratory but not swallowing function in a superoxide Dismutase-1 mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Lind","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2024.115025_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nmd.2016.11.008","article-title":"IGHMBP2-related clinical and genetic features in a cohort of Chinese Charcot-Marie-tooth disease type 2 patients","volume":"27","author":"Liu","year":"2017","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.expneurol.2024.115025_bb0125","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/hmg\/ddac283","article-title":"Clinically relevant mouse models of Charcot-Marie-tooth type 2S","volume":"32","author":"Martin","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/humu.9241","article-title":"Allelic heterogeneity of SMARD1 at the IGHMBP2 locus","volume":"23","author":"Maystadt","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2024.115025_bb0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nmd.2016.06.457","article-title":"Clinical and molecular characteristics in three families with biallelic mutations in IGHMBP2","volume":"26","author":"Pedurupillay","year":"2016","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.expneurol.2024.115025_bb0140","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/brain\/awg278","article-title":"Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1","volume":"126","author":"Pitt","year":"2003","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2014.09.010","article-title":"The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review","volume":"346","author":"Porro","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2024.115025_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.expneurol.2016.05.033","article-title":"Accessory respiratory muscles enhance ventilation in ALS model mice and are activated by excitatory V2a neurons","volume":"287","author":"Romer","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0155","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.nmd.2021.08.001","article-title":"Models for IGHMBP2-associated diseases: an overview and a roadmap for the future","volume":"31","author":"Rzepnikowska","year":"2021","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.expneurol.2024.115025_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2019.10.032","article-title":"Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd","volume":"520","author":"Shababi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2024.115025_bb0165","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddab317","article-title":"The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects","volume":"31","author":"Smith","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2024.115025_bb0170","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/wdev.230","article-title":"Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease","volume":"5","author":"Talbot","year":"2016","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164608","article-title":"ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity","volume":"8","author":"Vadla","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2024.115025_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167091","article-title":"The contribution and therapeutic implications of IGHMBP2 mutations on IGHMBP2 biochemical activity and ABT1 association","volume":"1870","author":"Vadla","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.expneurol.2024.115025_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nmd.2018.10.002","article-title":"Spinal muscular atrophy with respiratory distress type 1: a multicenter retrospective study","volume":"29","author":"Viguier","year":"2019","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.expneurol.2024.115025_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2015.09.024","article-title":"Exacerbation of Charcot-Marie-tooth type 2E neuropathy following traumatic nerve injury","volume":"1627","author":"Villalon","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.115025_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2019.06.117","article-title":"Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1","volume":"516","author":"Villalon","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2024.115025_bb0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.10182","article-title":"Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13","volume":"51","author":"Viollet","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2024.115025_bb0205","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.nmd.2015.07.017","article-title":"Autosomal recessive axonal polyneuropathy in a sibling pair due to a novel homozygous mutation in IGHMBP2","volume":"25","author":"Wagner","year":"2015","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.expneurol.2024.115025_bb0210","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1111\/ene.15024","article-title":"Genotype and phenotype distribution of 435 patients with Charcot-Marie-tooth disease from central South China","volume":"28","author":"Xie","year":"2021","journal-title":"European journal of neurology : the official journal of the European Federation of Neurological Societies"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624003510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624003510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:38:09Z","timestamp":1777430289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624003510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"alternative-id":["S0014488624003510"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115025","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ighmbp2 mutations and disease pathology: Defining differences that differentiate SMARD1 and CMT2S","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115025"}}